Consequences of screening in lung cancer: Development and dimensionality of a questionnaire

Value in Health

Volumn 13, Issue 5, 2010, Pages 601-612

  Brodersen, John ^a   Thorsen, Hanne ^a   Kreiner, Svend ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

lung cancer; psychometrics; public health; questionnaire development; secondary prevention

Indexed keywords

ANXIETY; ARTICLE; BEHAVIOR; CANCER SCREENING; COMPREHENSION; CONSEQUENCES OF SCREENING QUESTIONNAIRE IN LUNG CANCER; CONTENT ANALYSIS; CONTENT VALIDITY; EMPATHY; FALSE POSITIVE RESULT; IMPULSIVENESS; INTERVIEW; LUNG CANCER; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUESTIONNAIRE; RASCH ANALYSIS; RELIABILITY; RESPIRATORY TRACT DISEASE; SELF CONCEPT; SLEEP; SMOKING; SOCIAL INTERACTION; STIGMA; THEORY;

EID: 77950255474     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00697.x     Document Type: Article

References (58)

1. Dean C, Roberts MM, French K, Robinson S. Psychiatric morbidity after screening for breast cancer. J Epidemiol Community Health 1986 40 : 71 5.
2. Eardley A, Elkind A. Breast and cervical screening: looking at screening and its problems. Nurs Stand 1990 4 : 35 7.
3. Fallowfield LJ, Rodway A, Baum M. What are the psychological factors influencing attendance, non-attendance and re-attendance at a breast screening centre? J R Soc Med 1990 83 : 547 551.
4. Austoker J, Ong G. Written information needs of women who are recalled for further investigation of breast screening: results of a multicentre study. J Med Screen 1994 1 : 238 244.
5. Cullen J, Schwartz MD, Lawrence WF, et al. Short-term impact of cancer prevention and screening activities on quality of life. J Clin Oncol 2004 22 : 943 952.
6. Brett J, Bankhead C, Henderson B, et al. The psychological impact of mammographic screening. A systematic review. Psychooncology 2005 14 : 917 938.
7. Brodersen J. Measuring Psychosocial Consequences of False-Positive Screening Results - Breast Cancer As An Example. Copenhagen : Department of General Practice, Institute of Public Health, Faculty of Health Sciences, University of Copenhagen: Månedsskrift for Praktisk Lægegerning, 2006. ISBN: 87-88638-36-7.
8. Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value Health 2007 10 : 294 304.
9. Brodersen J, Thorsen H, Cockburn J. Validity of short-term consequences of cancer prevention and screening activities? J Clin Oncol 2005 23 : 244 245.
10. Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long-term consequences of false-positive screening mammography. J Med Screen 2004 11 : 39 44.
11. McGovern PM, Gross CR, Krueger RA, et al. False-positive cancer screens and health-related quality of life. Cancer Nurs 2004 27 : 347 352.
12. Hobart JC, Williams LS, Moran K, Thompson AJ. Quality of life measurement after stroke: uses and abuses of the SF-36. Stroke 2002 33 : 1348 1356.
13. Comins J, Brodersen J, Krogsgaard M, Beyer N. Rasch analysis of the Knee injury and Osteoarthritis Outcome Score (KOOS): a statistical re-evaluation. Scand J Med Sci Sports 2008 18 : 336 345.
14. Hagell P, Tornqvist AL, Hobart J. Testing the SF-36 in Parkinson's disease. Implications for reporting rating scale data. J Neurol 2008 255 : 246 254.
15. Hagell P, Relmer J, Nyberg P. Whose quality of life? Ethical implications in patient-reported health outcome measurement. Value Health 2009 12 : 613 617.
16. Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003 56 : 52 60.
17. Brodersen J, McKenna SP, Doward LC, Thorsen H. Measuring the psychosocial consequences of screening. Health Qual Life Outcomes 2007 5 : 3.
18. Bach PB, Jett JR, Pastorino U, et al. Computed tomography screening and lung cancer outcomes. JAMA 2007 297 : 953 961. (Pubitemid 46376749)
19. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999 354 : 99 105.
20. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002 165 : 508 513.
21. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003 362 : 593 597.
22. Welch HG, Woloshin S, Schwartz LM, et al. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med 2007 167 : 2289 2295.
23. The National Lung Screening Trial. Available from: http://www.cancer.gov/ nlst [Accessed April 28, 2009 M, Belli G, Zappa M, et al. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial. AJR Am J Roentgenol 2006 187 : 421 429.
24. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007 120 : 868 874.
25. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial - overall design and results of the prevalence round. J Thorac Oncol 2009 4 : 608 614.
26. Becker N, Delorme S, Kauczor HU. The German component of the European trial on the efficacy of multislice-CT for the early detection of lung cancer. Onkologie 2008 130 (Suppl. 1 130. Ref Type: Abstract.
27. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making 2008 28 : 917 925.
28. van den Bergh KA, Essink-Bot ML, Bunge EM, et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 2008 113 : 396 404.
29. Ashraf H, Tonnesen P, Pedersen JH, et al. Smoking habits were unaffected by CT screening at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009 64 : 388 392.
30. Spielberger CD, Gorsuch RL, Lushene RE, et al. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA : Consulting Psychologists Press, 1983.
31. Ong G, Austoker J, Brett J. Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study. J Med Screen 1997 4 : 158 168.
32. Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Public Health Med 1998 20 : 396 403.
33. Tenenbaum G, Furst D, Weingarten G. A statistical reevaluation of the STAI anxiety questionnaire. J Clin Psychol 1985 41 : 239 244.
34. Brodersen J, Thorsen H. Consequences of screening in breast cancer (COS-BC): development of a questionnaire. Scand J Prim Health Care 2008 26 : 251 256.
35. Elsass P. Sundhedspsykologi. København : Gyldendal, 1992.
36. Iversen L, Kristensen TS, Holstein B, Due P. Medicinsk Sociologi. København : Munksgaard Danmark, 2002.
37. Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry 1980 137 : 535 544.
38. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977 196 : 129 136.
39. Willis GB. Cognitive interviewing. A "How to" guide. Available from: http://appliedresearch.cancer.gov/areas/cognitive/interview.pdf [Accessed December 4, 2009 D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res 2003 12 : 229 238.
40. Jacobsen B, Jorgensen SD, Jorgensen SE. Kræft og eksistens - om at leve med kræft. Dansk Psykologisk Forlag 1998.
41. Carver CS, Antoni MH. Finding benefit in breast cancer during the year after diagnosis predicts better adjustment 5-8 years after diagnosis. Health Psychol 2004 23 : 595 598.
42. Antonovsky A. Health, Stress and Coping. San Francisco : Jossey-Bass Inc Pub, 1979.
43. Antonovsky A. Unraveling the Mystery of Health: How People Manage Stress and Stay Well. San Francisco : Jossey-Bass Inc Pub, 1987.
44. Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. Br J Cancer 1990 62 : 1018 1022.
45. McDowell I, Newell C. Measuring Health. A Guide to Rating Scales and Questionnaires (2nd ed.). Oxford : Oxford University Press, 1996.
46. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use (4th ed.). New York : Oxford University Press, 2008.
47. Andrich D, Luo G. Conditional pairwise estimation in the Rasch model for ordered response categories using principal components. J Appl Meas 2003 4 : 205 221.
48. RUMM 2020 [computer program]. Version 4.0 for Windows. RUMM Laboratory Pty Ltd. Available from: http://www.rummlab.com/ [Accessed December 4, 2009 BD, Panchapakesan N. A procedure for sample-free item analysis. Educ Psychol Meas 1969 29 : 23 48.
49. Rasch G. An informal report on a theory of objectivity in comparisons. In : Van der Kamp LJTH, Vlek CAJ, eds. Psychological Measurement Theory. Leyden : University of Leyden, 1967.
50. Andersen EB. Sufficient statistics and latent trait models. Psychometrika 1977 42 : 69 81.
51. Hagquist C, Andrich D. Is the sense of coherence-instrument applicable on adolescents? A latent trait analysis using Rasch modelling. Pers Individ Dif 2004 36 : 955 968.
52. Brodersen J, Meads DM, Kreiner S, et al. Methodological aspects of differential item functioning in the Rasch model. J Med Econ 2007 10 : 309 324.
53. Hagquist C. Psychometric properties of the psychosomatic problems scale: a Rasch analysis on adolescent data. Soc Indic Res 2008 86 : 511 523.
54. Cronbach LJ. Coeffcient alpha and the internal structure of tests. Psychometrika 1951 16 : 297 334.
55. Cronbach LJ. Internal consistency of tests: analyses old and new. Psychometrika 1988 53 : 63 70.
56. Smith EV, Jr. Evidence for the reliability of measures and validity of measure interpretation: a Rasch measurement perspective. In : Smith EV, Jr., Smith RM, eds. Introduction to Rasch Measurement. Theory, Models and Applications (1st ed.). Maple Grove, MN : JAM Press, 2004.
57. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol 1995 57 : 289 300.
58. Chapple A, Ziebland S, McPherson A. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. BMJ 2004 328 : 1470 1474.